# EFNS Guidelines for Diagnosis and Management of Neurological Complications of HIV : Cerebral toxoplasmosis

## Cerebral Toxoplasmosis

### Diagnosis

1. **Suspected Criteria:**
    - Progressive neurological deficits
    - Contrast-enhancing mass lesion(s) on CT/MRI
    - Successful response to treatment within 2 weeks

2. **If all criteria met:**
    - Diagnosis: **Cerebral Toxoplasmosis**

### Treatment

1. **Primary Therapy:**
    - **Pyrimethamine + Sulfadiazine:**
        - Pyrimethamine 200 mg load, then 50 mg/day (oral)
        - Sulfadiazine 1 g four times daily (oral)
    
2. **Alternative Therapies:**
    - Trimethroprim/sulfamethoxazol 2.5–5 mg/kg (TMP) q.i.d.
    - Pyrimethamine + Clarithromycin 1 g twice daily
    - Pyrimethamine + Azithromycin 600–1800 mg/day
    - Pyrimethamine + Dapsone 100 mg/day
    - Atovaquone 750 mg four times daily (oral)

3. **Duration:**
    - Continue primary or alternative therapy for 6 weeks

4. **Secondary Prophylaxis:**
    - Pyrimethamine 50 mg/day + Sulfadiazine 500 mg four times daily
    - Atovaquone 750 mg four times daily

### Monitoring
- Secondary prophylaxis can be stopped if CD4 cell counts increase above 200 cells/µl and remain for at least 3 months.

---

[Original Source](https://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2004.00856.x)
